glp 1 receptor agonists and dpp 4 inhibitors do not combine dpp-4 with glp-1 guidance SGLT-2 inhibitors, Current Insights, Advantages and Challenges

The genetic test reveals predispositions in peptide pathways, not pharmacogenomic responses or guarantees of exact medication efficacy

Glucagon receptor signaling regulates energy metabolism via hepatic farnesoid X receptor and fibroblast growth factor 21

[DOI] [PMC free article] [PubMed] [Google Scholar] 913.Muller T.D., Sullivan L.M., Habegger K., Yi C.X., Kabra D., Grant E

In June 2024, researchers found that the decline in coronary heart disease rates among people under 60 in the UK stalled, likely due to rising obesity rates

These agents protect cells from inflammatory harm by reducing oxidative stress and supporting tissue equilibrium

Waldrop SW, Johnson VR, Stanford FC